The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients

BACKGROUND: The standard recommendation for neoadjuvant therapy for human epidermal growth factor receptor-2 (HER2)-positive breast cancer patients is trastuzumab in combination with chemotherapy, but there is no current standard recommendation for appropriate chemotherapy regimens. This meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yuqin, Ding, Kaijing, He, Xiangming, Mo, Wenju, Liang, Chenlu, Gong, Lijie, Huang, Yuting, Ding, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515528/
https://www.ncbi.nlm.nih.gov/pubmed/37744425
http://dx.doi.org/10.1177/11795549231195293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515528/
https://www.ncbi.nlm.nih.gov/pubmed/37744425
http://dx.doi.org/10.1177/11795549231195293

Ejemplares similares